Amgen Inc vs. Curis Inc
Amgen Inc (AMGN) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| AMGN | CRIS | |
|---|---|---|
| Market Cap | $222.32 billion | $7.83 million |
| Revenue (TTM) | $38.09 billion | $7.06 million |
| Net Income (TTM) | $8.74 billion | $-21,165,000 |
AMGN leads on 3 of 3 size & scale factors.
Valuation
| AMGN | CRIS | |
|---|---|---|
| P/E Ratio | 25.52 | — |
| Price / Book | 19.02 | 0.62 |
| Price / Sales | 5.84 | 1.11 |
CRIS leads on 2 of 2 valuation factors.
Profitability
| AMGN | CRIS | |
|---|---|---|
| Net Margin | 22.95% | -299.66% |
| Return on Equity | 74.80% | -166.56% |
AMGN leads on 2 of 2 profitability factors.
Dividend
| AMGN | CRIS | |
|---|---|---|
| Dividend Yield | 2.45% | — |
| Payout Ratio | 62.61 | — |
AMGN and CRIS split the dividend factors evenly.
Risk & Sentiment
| AMGN | CRIS | |
|---|---|---|
| Short Interest | 1.67% | 73.01% |
AMGN leads on 1 of 1 risk & sentiment factors.
Dig deeper: AMGN overview, AMGN financials, CRIS overview, CRIS financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.